GO Term |
---|
extrinsic component of synaptic vesicle membrane |
intracellular membrane-bounded organelle |
nucleoplasm |
cytosol |
peroxisomal matrix |
centrosome |
spindle |
site of double-strand break |
DNA repair complex |
nucleus |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
601 |
|
|||
935 |
|
|||
941 |
|
|||
1731 |
|
|||
2608 |
|
|||
2636 |
|
|||
2902 |
|
|
Pathway Name | Organism |
---|---|
Autodegradation of the E3 ubiquitin ligase COP1 | Homo sapiens |
DNA Damage/Telomere Stress Induced Senescence | Homo sapiens |
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | Homo sapiens |
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | Homo sapiens |
Defective homologous recombination repair (HRR) due to BRCA1 loss of function | Homo sapiens |
G2/M DNA damage checkpoint | Homo sapiens |
HDR through Homologous Recombination (HRR) | Homo sapiens |
HDR through Single Strand Annealing (SSA) | Homo sapiens |
Homologous DNA Pairing and Strand Exchange | Homo sapiens |
Impaired BRCA2 binding to PALB2 | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0050671 | female breast cancer | |
DOID:12704 | ataxia telangiectasia | |
DOID:1380 | endometrial cancer | |
DOID:14330 | Parkinson's disease | |
DOID:1612 | breast cancer | |
DOID:1793 | pancreatic cancer | |
DOID:3907 | lung squamous cell carcinoma | |
DOID:3908 | lung non-small cell carcinoma | |
DOID:3969 | papillary thyroid carcinoma | |
DOID:5409 | lung small cell carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025